HNGE vs AMWL vs KO vs OMCL vs TDOC

For growth investors, Hinge Health, Inc.

(HNGE) is the stronger pick with 50. 6% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). The Coca-Cola Company (KO) offers the better valuation at 27. 2x trailing P/E (25. 3x forward), making it the more compelling value choice. Analysts rate Hinge Health, Inc. (HNGE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, The Coca-Cola Company (KO) is the cheapest at 27.

2x versus Omnicell, Inc. at 854. 0x. On forward P/E, Omnicell, Inc. is actually cheaper at 19. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hinge Health, Inc.

(HNGE) delivered a total return of +74. 0%, compared to -96. 7% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: KO returned +121. 1% versus AMWL's -98. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Coca-Cola Company (KO) is the lower-risk stock at -0.

20β versus Teladoc Health, Inc. 's 1. 85β — meaning TDOC is approximately -1026% more volatile than KO relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 133% for The Coca-Cola Company — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Hinge Health, Inc.

(HNGE) is pulling ahead at 50. 6% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -33. 6% for Hinge Health, Inc.. Over a 3-year CAGR, KO leads at 3. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Coca-Cola Company (KO) is the more profitable company, earning 27.

3% net margin versus -89. 9% for Hinge Health, Inc. — meaning it keeps 27. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: KO leads at 28. 7% versus -92. 9% for HNGE. At the gross margin level — before operating expenses — HNGE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Omnicell, Inc.

(OMCL) trades at 19. 5x forward P/E versus 26. 0x for Hinge Health, Inc. — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMCL: 51. 2% to $57. 20.

In this comparison, KO (2.

5% yield) pays a dividend. HNGE, AMWL, OMCL, TDOC do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Coca-Cola Company (KO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.

20), 2. 5% yield, +121. 1% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (KO: +121. 1%, TDOC: -41. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (HNGE (Healthcare) and AMWL (Healthcare) and KO (Consumer Defensive) and OMCL (Healthcare) and TDOC (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HNGE is a small-cap high-growth stock; AMWL is a small-cap quality compounder stock; KO is a large-cap quality compounder stock; OMCL is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock. KO pays a dividend while HNGE, AMWL, OMCL, TDOC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.